| | |  | | | | Record from Web of Science® | | | | | | |
| Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors |
|
|
| Author(s): Murata M, Harada M, Kato S, Takahashi S, Ogawa H, Okamoto S, Tsuchiya S, Sakamaki H, Akiyama Y, Kodera Y |
| Source: BONE MARROW TRANSPLANTATION Volume: 24 Issue: 10 Pages: 1065-1071 Published: NOV 1999 |
| Times Cited: 38 References: 28 |
| Abstract: Adverse events were analyzed in 94 normal donors who underwent PBSC harvest with G-CSF. The median dose of G-CSF was 9.7 mu g/kg/day (range, 2.0-16.7), and the duration of administration was 4-6 days. Frequent symptoms were bone pain (71%), general fatigue (33%), headache (28%), insomnia (14%), anorexia (11%), nausea and/or vomiting (11%), One donor (1%) developed grade 3 toxicity bone pain (WHO criteria). WBC counts and ANC increased during G-CSF administration. After leukapheresis, three donors (3%) developed grade 3 toxicity neutropenia, Platelet counts decreased after leukapheresis. Three donors (3%) developed grade 3 thrombocytopenia, The means of both ALP and LDH increased approximately 1.9-fold compared with pretreatment levels. In one pediatric donor (1%), ALP was elevated to the grade 3 toxicity level. From multivariate analysis, the incidence of bone pain increased when G-CSF was given at a dose of 8.8 mu g/kg/day or more, headaches were frequent in donors younger than 35 years, and the incidence of nausea and/or vomiting was high in female donors. The peak levels of WBC counts and ANC and post-treatment level of LDH increased in correspondence with the escalation of G-CSF dose. All adverse events normalized on follow-up evaluation. In conclusion, although PBSC harvest for normal donors is acceptable, care must be taken for all donors in terms of their sex and age as well as the G-CSF dose. We recommend less than 8.8 mu g/kg/day as the G-CSF dose for PBSC mobilization in normal donors. |
| Document Type: Article |
| Language: English |
| Reprint Address: Murata, M (reprint author), Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 466 Japan |
Addresses:
1. Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, Nagoya, Aichi 466 Japan
2. Japanese Red Cross Nagoya First Hosp, Dept Internal Med, Div Hematol, Nagoya, Aichi Japan
3. Okayama Univ, Sch Med, Dept Internal Med 2, Okayama, Japan
4. Tokai Univ, Sch Med, Dept Pediat, Kanagawa, Japan
5. Univ Tokyo, Inst Med Sci, Tokyo, Japan
6. Osaka Univ, Sch Med, Dept Med 3, Osaka, Japan
7. Keio Univ, Sch Med, Div Hematol, Tokyo, Japan
8. Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi Japan
9. Tokyo Metorpolitan Komagome Hosp, Bone Marrow Transplantat Team, Tokyo, Japan
10. Kyoto Univ, Dept Pediat, Kyoto, Japan |
| Publisher: STOCKTON PRESS, HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND |
| Subject Category: Biophysics; Oncology; Hematology; Immunology; Transplantation |
| IDS Number: 260CU |
| ISSN: 0268-3369 |
|
| | | | | | | | | Record from Web of Science® | | | | | | | | | |